November 21st 2024
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
Study: Use of Preoperative MRI 46 Percent Less Likely for Black Women with Breast Cancer
July 11th 2024In the study of over 1,400 women with breast cancer, researchers noted that Black women with dense breasts or lobular histology were significantly less likely to have preoperative MRI exams than White women with the same clinical characteristics.
Can AI Facilitate Effective Triage for Supplemental Breast MRI After Negative Mammography Screening?
July 10th 2024The AISmartDensity software facilitated a cancer detection rate (CDR) with breast MRI that was nearly four times higher than the CDR previously reported in trials involving traditional breast density assessment.
Mammography and Breast MRI: Is it Time to Evaluate Strategies as Opposed to Modalities?
July 5th 2024The combination of mammography with breast MRI within 90 days had a 96.2 percent sensitivity in comparison to 48.1 percent for mammography and 79.7 percent for breast MRI performed within 91 to 270 days after index mammography, according to newly published research.
MRI Workflow Adjustments Lead to Nearly 35 Percent Decline in Exam Delays for Sedated Patients
June 20th 2024Targeting improvements in workflow, patient consent protocols and adherence to scheduled exam times, researchers noted significant reductions in 15-minute and 30-minute delays with MRI exams for patients who required sedation or general anesthesia.
Breast MRI Study: Can Node-RADS Scoring Enhance Detection of Lymph Node Invasion in Breast Cancer?
June 17th 2024Employing a cut-off of Node-RADS > 2 for differentiating malignant lymph nodes with breast MRI in women with breast cancer, researchers noted average sensitivity and specificity rates of 91.5 percent and 87.4 percent respectively.
Study: Adjunctive AI Imaging Software Enhances Contouring of Prostate Cancer
June 13th 2024Artificial intelligence (AI) assisted contouring of prostate cancer demonstrated superior balanced accuracy than manual standard-of-care contouring and hemigland contouring with MRI, according to a new study.
Essential Keys to MRI Safety in the Age of Advanced Diagnostics
June 6th 2024As ongoing advances continue to redefine and elevate the diagnostic capabilities of MRI, ensuring the safety of patients and operators through effective signage, training and regular safety audits is of paranount importance.
Researchers Unveil PI-QUAL v2 for Prostate MRI Quality Assessments
May 28th 2024Developed by an extended prostate cancer working group of the European Society of Urogenital Radiology (ESUR), the updated PI-QUAL scoring system emphasizes a simplified scale of image parameters that applies to prostate MRI scans with and without intravenous contrast use.
Abbreviated Breast MRI and Dense Breasts: What Emerging Research Reveals
May 22nd 2024In a study of over 2,000 women with dense breasts and average breast cancer risk, abbreviated MRI (AB-MR) demonstrated an 18.9 per 1000 cancer detection rate (CDR) in baseline exams, and all cancers detected with baseline or subsequent AB/MR exams were stage 0 or 1.
Study: PSMA PET/CT Agent May Rule Out csPCa in 93 Percent of PI-RADS 3 Lesions
May 22nd 2024New prospective research examining the utility of 18F-PSMA-1007 PET/CT revealed comparable sensitivity to mpMRI for detecting clinically significant prostate cancer and a 17 percent higher specificity rate.